Antibiotic or Not in Non-purulent Exacerbations of COPD: a Trial of Security and Efficacy

NCT01091493 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Moxifloxacin

Sponsor

Fundacion Clinic per a la Recerca Biomédica

Collaborators

[object Object]